Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.2.1.6: acetolactate synthase

This is an abbreviated version!
For detailed information about acetolactate synthase, go to the full flat file.

Word Map on EC 2.2.1.6

Reaction

2 pyruvate =

2-acetolactate
+
CO2

Synonyms

aceto-hydroxy acid synthase, acetohydroxy acid synthase, acetohydroxy acid synthase I, acetohydroxy acid synthetase, acetohydroxyacid synthase, acetolactate pyruvate-lyase (carboxylating), acetolactate synthase, acetolactate synthetase, acetolactate-synthase, acetolactic synthetase, AHAS, AHAS II, AHAS1, AHAS2, AHAS3, AHASL, AHASS, alpha-acetohydroxy acid synthetase, alpha-acetohydroxyacid synthase, alpha-acetolactate synthase, alpha-acetolactate synthetase, alpha-ALS, ALS, ALS1, ALS1R, ALS2, AlsS, CalS, catabolic acetolactate synthase, EC 4.1.3.18, GST-mALS, GST-wALS, Ilv2, Ilv6, ilvB, ilvB1, ilvB2, ilvG, IlvN, ilvX, Moilv2, Moilv6, More, PF0935, sll1981, synthase, acetolactate, TM_0548, TM_0549, TTHA1213

ECTree

     2 Transferases
         2.2 Transferring aldehyde or ketonic groups
             2.2.1 Transketolases and transaldolases
                2.2.1.6 acetolactate synthase

Engineering

Engineering on EC 2.2.1.6 - acetolactate synthase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
A122V
A205F
site-directed mutagenesis, the enzyme mutation confers resistance to imidazolinone, sulfonylurea, triazolopyrimidines, sulfonylaminocarbonyl triazolinones, and pyrimidinyl(thio)benzoate herbicides
A205V
site-directed mutagenesis
G121A
Nicotiana tabacum plants with transplastomic expression of mutant are specifically tolerant to pyrimidinylcarboxylate, imidazolinon, and sulfonylurea/pyrimidinylcarboxylate herbicides, respectively
M124E
-
naturally occuring mutation
P197L
-
the mutation causes serious cross-resistance to most types of enzyme inhibitors
P197S
R199E
-
naturally occuring mutation
S653F
-
naturally occuring mutation
S653N
S653T
-
naturally occuring mutation
W574L
W574S
H28A
-
site-directed mutagenesis, the mutant enzyme is much less able to catalyze the C-C bond formation as the wild-type enzyme, while the ability for C-C bond cleavage is still intact, the H28A variant shows an 8fold decrease in the formation of (R)-phenylacetylcarbinol (12%), but 1,2-diketone cleavage is nearly unaffected (78% conversion)
H28A/N484A
-
site-directed mutagenesis, the double mutant catalyzes the addition of pyruvate to cyclohexane-1,2-dione, resulting in the formation of a tertiary alcohol, variant H28A/N484A shows acceptable formation of (R)-phenylacetylcarbinol (73%), but conversion toward the cleavage product is decreased by a factor of five (17% conversion), the mutant is also active with 1,2-diketone, e.g. cyclohexane-1,2-dione, in contrast to the wild-type enzyme, mutant substrate specificity amd enantioselectivity, overview
H76A
-
site-directed mutagenesis, almost inactive mutant
H76A/Q116A
-
site-directed mutagenesis, inactive mutant
N484A
-
site-directed mutagenesis
Q116A
-
site-directed mutagenesis, inactive mutant
H28A
-
site-directed mutagenesis, the mutant enzyme is much less able to catalyze the C-C bond formation as the wild-type enzyme, while the ability for C-C bond cleavage is still intact, the H28A variant shows an 8fold decrease in the formation of (R)-phenylacetylcarbinol (12%), but 1,2-diketone cleavage is nearly unaffected (78% conversion)
-
H28A/N484A
-
site-directed mutagenesis, the double mutant catalyzes the addition of pyruvate to cyclohexane-1,2-dione, resulting in the formation of a tertiary alcohol, variant H28A/N484A shows acceptable formation of (R)-phenylacetylcarbinol (73%), but conversion toward the cleavage product is decreased by a factor of five (17% conversion), the mutant is also active with 1,2-diketone, e.g. cyclohexane-1,2-dione, in contrast to the wild-type enzyme, mutant substrate specificity amd enantioselectivity, overview
-
H76A
-
site-directed mutagenesis, almost inactive mutant
-
Q116A
-
site-directed mutagenesis, inactive mutant
-
K176G
the naturally occuring mutation, substitution of two adenines to guanines in the ilvB gene, causes a cold-sensitive phenotype of mutant strain JH642. The acetolactate synthase efficiency in strain JH642 is reduced by 51fold
K40H
site-directed mutagenesis, the half-life of the mutant at 50°C is 44 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows reduced activity compared to the wild-type
K40Y
site-directed mutagenesis, the half-life of the mutant at 50°C is 110 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows reduced activity compared to the wild-type
M483N
site-directed mutagenesis, the mutant is inactivated at 50°C
P87A
site-directed mutagenesis, the half-life of the mutant at 50°C is 33 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows reduced activity compared to the wild-type
Q124S
site-directed mutagenesis, the half-life of the mutant at 50°C is 42 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows reduced activity compared to the wild-type
Q424S
site-directed mutagenesis, the half-life of the mutant at 50°C is 104 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows increased activity compared to the wild-type
Q424S/Q487S
site-directed mutagenesis, the half-life of the mutant at 50°C is 94 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows highly reduced activity compared to the wild-type
Q487A
Q487G
Q487I
Q487L
Q487S
T84V
site-directed mutagenesis, the half-life of the mutant at 50°C is 2.5 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows highly reduced activity compared to the wild-type
Y481A
site-directed mutagenesis, the half-life of the mutant at 50°C is 19 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows highly reduced activity compared to the wild-type
Q487A
-
wild-type additionally catalyzes the decarboxylation of 2-oxoisovalerate. Mutation diminishes only the decarboxylase activity but maintains the acetolactate synthase activity
-
Q487G
-
wild-type additionally catalyzes the decarboxylation of 2-oxoisovalerate. Mutation diminishes only the decarboxylase activity but maintains the acetolactate synthase activity
-
Q487I
-
loss of acetolactate synthase activity, decrease in decarboxylase activity
-
Q487L
-
loss of acetolactate synthase activity, decrease in decarboxylase activity
-
Q487S
-
wild-type additionally catalyzes the decarboxylation of 2-oxoisovalerate. Mutation diminishes only the decarboxylase activity but maintains the acetolactate synthase activity
-
K40H
-
site-directed mutagenesis, the half-life of the mutant at 50°C is 44 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows reduced activity compared to the wild-type
-
K40I
-
site-directed mutagenesis, the half-life of the mutant at 50°C is 89 h, compared to 81 h for the wild-type enzyme, the mutant enzyme shows highly reduced activity compared to the wild-type
-
Q487S
S638N
-
the mutant is more resistant to imidazolinone herbicides than the wild type in contrast to sulfonylurea herbicides that inhibit the mutant as well as the wild type enzyme
W557L
-
naturally occuring mutation
D376E
-
the resistance mutation causes more than 200fold resistance to tribenuron-methyl and also greatly reduces the enzyme sensitivity to tribenuron-methyl and increases enzyme binding affinity for the substrate pyruvate
P197H
-
the resistance mutation causes more than 200fold resistance to tribenuron-methyl and also greatly reduces the enzyme sensitivity to tribenuron-methyl and increases enzyme binding affinity for the substrate pyruvate
P197L
-
the resistance mutation causes more than 200fold resistance to tribenuron-methyl and also greatly reduces the enzyme sensitivity to tribenuron-methyl and increases enzyme binding affinity for the substrate pyruvate
P197T
-
the resistance mutation causes more than 200fold resistance to tribenuron-methyl and also greatly reduces the enzyme sensitivity to tribenuron-methyl and increases enzyme binding affinity for the substrate pyruvate
W574L
-
the resistance mutation causes more than 200fold resistance to tribenuron-methyl and also greatly reduces the enzyme sensitivity to tribenuron-methyl and increases enzyme binding affinity for the substrate pyruvate
H111F
H111R
Q112E
Q112N
Q112V
Q411E
Q411N
A108V
-
naturally occuring mutation
A36V
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
C83A
-
about 91% of wild-type activity
C83S
-
about 126% of wild-type activity
C83T
-
about 41% of wild-type activity
D428E
-
8% activity compared to wild-type
D428N
-
8% activity compared to wild-type
E60A
-
about 48% of wild-type activity
E60Q
-
about 1% of wild-type activity
F109M
-
both substrate affinity and kcat are significantly compromised. The specificity for 2-ketobutyrate as acceptor is not altered
G14A
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
G14D
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
L131R
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
L16A
-
site-directed mutagenesis of the regulatory subunit, the mutant shows increased sensitivity to valine inhibition compared to the wild-type subunit
L476M
-
about 34% of wild-type activity
L476M/Q480W
-
about 47% of wild-type activity
L9A
-
site-directed mutagenesis of the regulatory subunit, the mutant shows slightly decreased sensitivity to valine inhibition compared to the wild-type subunit
L9H
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
L9V
-
site-directed mutagenesis of the regulatory subunit, the mutant shows slightly decreased sensitivity to valine inhibition compared to the wild-type subunit
M250A
-
large decrease in activity, increase in Km-value
M263A
-
about 16% of wild-type activity
M460N
-
naturally occuring mutation
N11A
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
N11D
-
site-directed mutagenesis of the regulatory subunit, the mutant shows highly decreased sensitivity to valine inhibition compared to the wild-type subunit
N11H
-
site-directed mutagenesis of the regulatory subunit, the mutant shows highly decreased sensitivity to valine inhibition compared to the wild-type subunit
N29D
-
site-directed mutagenesis of the regulatory subunit, the mutant shows highly decreased sensitivity to valine inhibition compared to the wild-type subunit
N29H
-
site-directed mutagenesis of the regulatory subunit, the mutant shows highly decreased sensitivity to valine inhibition compared to the wild-type subunit
Q110A
-
about 3% of wild-type activity
Q110E
-
about 1.5% of wild-type activity
Q110H
-
about 15% of wild-type activity
Q110N
-
about 8% of wild-type activity
Q480W
-
about 22% of wild-type activity
R269Q
-
about 0.5% of wild-type activity
R276K
-
large decrease in activity, increase in Km-value
R289K
-
about 11% of wild-type activity
T34C
-
site-directed mutagenesis of the regulatory subunit, the mutant shows decreased sensitivity to valine inhibition compared to the wild-type subunit
T34I
-
site-directed mutagenesis of the regulatory subunit, the mutant shows highly decreased sensitivity to valine inhibition compared to the wild-type subunit
T47C
-
site-directed mutagenesis of the regulatory subunit, the mutant shows decreased sensitivity to valine inhibition compared to the wild-type subunit
V153D
-
site-directed mutagenesis of the regulatory subunit, the mutant is resistant to inhibition by valine
V35A
-
site-directed mutagenesis of the regulatory subunit, the mutant shows decreased sensitivity to valine inhibition compared to the wild-type subunit
V375A
V375I
-
slightly reduced kcat value with a moderate increase of the apparent KM of pyruvate. The specificity for 2-ketobutyrate as acceptor is not altered
V391A
-
about 3% of wild-type activity
V477I
-
about 8% of wild-type activity
W464A
-
naturally occuring mutation
W464L
W464Q
-
naturally occuring mutation
W464Y
-
naturally occuring mutation
W46F
-
naturally occuring mutation
W563C
naturally occuring mutation
W563S
naturally occuring mutation
A205V
-
naturally occuring mutation
F147A
4fold decrease in vmax value, strong resistance to sulfonylurea inhibitors
F147R
2.5fold decrease in vmax value, strong resistance to sulfonylurea inhibitors
L141A
5fold decrease in vmax value
P126A
site-directed mutagenesis, the mutant exhibits similar kinetics but significantly lower activity compared to the wild-type enzyme
P126A,
the mutant exhibits significantly lower activity than the wild type enzyme
P126E
P126T
P126V
W561R
30fold decrease in vmax value, strong resistance to sulfonylurea inhibitors
E85A
-
site-directed mutagenesis, the mutation leads to severe drop in catalyticactivity with reduced affinity toward thiamine diphosphate, , the enzyme shows reduced activity compared to the wild-type enzyme
-
F147A
-
4fold decrease in vmax value, strong resistance to sulfonylurea inhibitors
-
F147R
-
2.5fold decrease in vmax value, strong resistance to sulfonylurea inhibitors
-
L141A
-
5fold decrease in vmax value
-
P126A
-
site-directed mutagenesis, the mutant exhibits similar kinetics but significantly lower activity compared to the wild-type enzyme
-
P126A,
-
the mutant exhibits significantly lower activity than the wild type enzyme
-
P126E
P126T
P126V
W561R
-
30fold decrease in vmax value, strong resistance to sulfonylurea inhibitors
-
P197E
A121T
-
naturally occuring mutation
C163S
-
labile, readlily degraded
C309S
-
labile, readlily degraded
C411A
-
no enzymic activity, no binding of FAD
C607S
-
no significant effects
D374A
D374A/D375A
-
strong resistance to Londax and to C, about 2fold increase in affinity for FAD, decrease in activation efficiency for thiamine diphosphate
D374E
-
greatly reduced activity, strong resistance to Londax, 8fold increase in affinity for FAD, decrease in activation efficiency for thiamine diphosphate
D374E/D375E
-
strong resistance to Londax and to C
D375A
D375E
DELTA567
-
deletion of entire C-terminus including mobile loop and C-terminal lid, no enzymic activity
DELTA567-582
-
deletion of mobile loop region 4.5% of activity compared to wild-type, increase in activation constant of thiamine diphosphate
DELTA598
-
deletion of c-terminus maintaining mobile loop and C-terminal lid, 1.2% of activity compared to wild-type
DELTA630
-
deletion of C-terminal lid, 4.5% of activity compared to wild-type, increase in activation constant of thiamine diphosphate
F577D
-
naturally occuring mutation
F577E
-
naturally occuring mutation
H351F
-
5fold increase in Km-value, weak resistance to Londax and Cadre, difference in secondary structure compared to wild-type
H351M
-
18fold increase in Km-value, strong resistance to Londax and Cadre, difference in secondary structure compared to wild-type
H351Q
H392M
-
no significant effects
H487F
-
no enzymic activity, no affinity for FAD
H487L
-
no enzymic activity, no affinity for FAD
K219Q
-
no residual activity, no binding of FAD
K255F
K255Q
K299Q
-
no significant effects
M350C
-
naturally occuring mutation
M569C
-
naturally occuring mutation
R141A
-
site-directed mutagenesis, inactive mutant, unable to bind the cofactor FAD
R141F
-
site-directed mutagenesis, inactive mutant, unable to bind the cofactor FAD
R141K
-
site-directed mutagenesis, the mutant shows reduced activity and activation by thiamine diphosphate compared to the wild-type enzyme, the mutant is partially resistant to herbicides, e.g. Londax, Cadre, and/or TP
R372F
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme, the mutant is partially resistant to herbicides, e.g. Londax, Cadre, and/or TP
R372K
-
site-directed mutagenesis, the mutant shows reduced activity and activation by FAD compared to the wild-type enzyme, the mutant is partially resistant to herbicides, e.g. Londax, Cadre, and/or TP
R372S/F373P/D374V
-
site-directed mutagenesis, mutation of the conserved motif 372RFDDR376 results in abolished FAD binding and highly reduced activity
R372S/F373P/D374V/D375E
-
site-directed mutagenesis, mutation of the conserved motif 372RFDDR376 results in abolished FAD binding and highly reduced activity
R372S/F373P/D374V/D375E/R376Y
-
site-directed mutagenesis, mutation of the conserved motif 372RFDDR376 results in abolished FAD binding and highly reduced activity, the mutant is resistant to herbocides
R376F
-
site-directed mutagenesis, inactive mutant, unable to bind the cofactor FAD
R376K
-
site-directed mutagenesis, the mutant shows reduced activity and activation by FAD compared to the wild-type enzyme, the mutant is partially resistant to herbicides, e.g. Londax, Cadre, and/or TP
S167A
-
73% of wild-type activity
S167F
-
inactive, mutation abolishes the binding affinity for cofactor FAD. The far-UV spectrum is similar to wild-type
S167R
-
250% of wild-type activity
S506A
-
230% of wild-type activity
S506F
-
inactive, mutation abolishes the binding affinity for cofactor FAD. The far-UV spectrum is similar to wild-type
S506R
-
183% of wild-type activity
S539A
-
73% of wild-type activity, strong resistance to herbicides NC-311, a sulfonylurea, Cadre, an imidazolinone, and a triazolopyrimidine
S539F
-
171% of wild-type activity, strong resistance to herbicides NC-311, a sulfonylurea, Cadre, an imidazolinone, and a triazolopyrimidine
S539R
-
30% of wild-type activity
S652T
-
naturally occuring mutation
V570Q
-
naturally occuring mutation
W573F
-
site-directed mutagenesis, the mutant shows 69fold reduced activity compared to the wild-type enzyme, substitution of the W573 residue causes significant perturbations in the activation process and in the binding site of thiamine diphosphate
A96T
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
A96V
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
F180R
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
G95A
the naturally occuring mutation leads to resistance against pyrimidinyl carboxy herbicides, e.g. bispyribac-sodium
M98E
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
M98H
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
M98I
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
P171A
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
P171Q
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
P171S
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
R173A
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
R173E
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
S627D
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
S627F
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
S627I
S627N
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
S627T
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
W548C
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
W548F
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
W548L
W548L/S627I
W548S
the naturally occuring mutation reduces the enzyme's sensitivity to herbicides
S627N
the mutation confers tolerance against imidazolinone herbicides, including imazethapyr and imazamox. The mutant is tolerant to imidazolinone but the catalytic efficiency of the mutated enzyme decreases in its presence. Moreover, the activity of the mutated enzyme decreases more in the presence of imazethapyr than in the presence of imazamox
P197A
mutation confers resistance to herbicide tribenuron. Mutation results in altered secondary structure, which stabilizes an ALS tertiary conformation that prevents tribenuron binding. Most common mutation among 28 populations resistant to tribenuron
P197L
mutation confers resistance to herbicide tribenuron. Mutation results in altered secondary structure, which stabilizes an ALS tertiary conformation that prevents tribenuron binding
P197R
mutation confers resistance to herbicide tribenuron. Mutation results in altered secondary structure, which stabilizes an ALS tertiary conformation that prevents tribenuron binding
P197S
mutation confers resistance to herbicide tribenuron. Mutation results in altered secondary structure, which stabilizes an ALS tertiary conformation that prevents tribenuron binding
P197T
mutation confers resistance to herbicide tribenuron. Mutation results in altered secondary structure, which stabilizes an ALS tertiary conformation that prevents tribenuron binding
A205F
A205V
the mutation confers resistance to imidazolinones, sulfonylureas, triazolopyrimidines, sulfonylamino-carbonyl-triazolinones, and pyrimidinyl (thio) benzoate herbicides
W574L
A117D
naturally occuring mutation
A117E
naturally occuring mutation
A117F
naturally occuring mutation
A117H
naturally occuring mutation
A117I
naturally occuring mutation
A117K
naturally occuring mutation
A117L
naturally occuring mutation
A117M
naturally occuring mutation
A117N
naturally occuring mutation
A117P
naturally occuring mutation
A117Q
naturally occuring mutation
A117R
naturally occuring mutation
A117S
naturally occuring mutation
A117T
naturally occuring mutation
A117V
naturally occuring mutation
A117W
naturally occuring mutation
A117Y
naturally occuring mutation
A200C
naturally occuring mutation
A200D
naturally occuring mutation
A200E
naturally occuring mutation
A200R
naturally occuring mutation
A200T
naturally occuring mutation
A200V
naturally occuring mutation
A200W
naturally occuring mutation
A200Y
naturally occuring mutation
A26V
naturally occuring mutation
D379E
naturally occuring mutation
D379G
naturally occuring mutation
D379N
naturally occuring mutation
D379P
naturally occuring mutation
D379S
naturally occuring mutation
D379V
naturally occuring mutation
D379W
naturally occuring mutation
F204A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
F590C
naturally occuring mutation
F590G
naturally occuring mutation
F590L
naturally occuring mutation
F590N
naturally occuring mutation
F590R
naturally occuring mutation
G116N
naturally occuring mutation
G116S
naturally occuring mutation
H181A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
H205A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
H219A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
K218A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
K251D
naturally occuring mutation
K251E
naturally occuring mutation
K251N
naturally occuring mutation
K251P
naturally occuring mutation
K251T
naturally occuring mutation
L177A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
L222A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
M354C
naturally occuring mutation
M354K
naturally occuring mutation
M354V
naturally occuring mutation
P192A
naturally occuring mutation
P192E
naturally occuring mutation
P192L
naturally occuring mutation
P192Q
naturally occuring mutation
P192R
naturally occuring mutation
P192S
naturally occuring mutation
P192V
naturally occuring mutation
P192W
naturally occuring mutation
P192Y
naturally occuring mutation
P206A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
R216A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
S212A
-
site-directed mutagenesis, the mutant shows reduced stimulation by MgATP2- and decreased Ki with valine compared to the wild-type enzyme
V583A
naturally occuring mutation
V583C
naturally occuring mutation
V583N
naturally occuring mutation
V583Y
naturally occuring mutation
V99M
naturally occuring mutation
W586A
naturally occuring mutation
W586C
naturally occuring mutation
W586E
naturally occuring mutation
W586G
naturally occuring mutation
W586H
naturally occuring mutation
W586I
naturally occuring mutation
W586K
naturally occuring mutation
W586L
naturally occuring mutation
W586N
naturally occuring mutation
W586S
naturally occuring mutation
W586V
naturally occuring mutation
P197S
P197T
W574L
G654D
-
mutant isolated from Ontario population. Mutant confers resistance to herbicide imazethapyr, and cross-resistance to nicosulfuron and flucarbazone
S653I
-
mutant isolated from Ontario population. Mutant confers resistance to herbicide imazethapyr, and cross-resistance to nicosulfuron and flucarbazone
S653N
-
mutant isolated from Ontario population. Mutant confers resistance to herbicide imazethapyr, and cross-resistance to nicosulfuron and flucarbazone
S653T
-
mutant isolated from Ontario population. Mutant confers resistance to herbicide imazethapyr, and cross-resistance to nicosulfuron and flucarbazone
DeltaQ217
E139A
G16D
mutation in the N-terminal part of the regulatory subunit ilvN, affecting regulation by valine. Mutation considerably reduces the interaction of the subunits
G16D/E105stop
no enzymic activity after in vitro reconstitution with large subunit
I106V/A135P
after in vitro reconstitution with large subunit, enzymic activity comparable to wild-type
Q108stop
no enzymic activity after in vitro reconstitution with large subunit
V17D/F30L
no enzymic activity after in vitro reconstitution with large subunit
H474R
H747R
mutation leads to 3fold increased acetaldehyde formation, with 30% decrease in acetolactate formation
K139R
V172A
Y35N/K139R/V172A/H474R
K139R
additional information